AI assistant
HOLISTA COLLTECH LIMITED — Capital/Financing Update 2020
Mar 3, 2020
65044_rns_2020-03-03_f64e198f-0bb6-4617-b614-93c5aca7e852.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [215 x 49] intentionally omitted <==
Holista CollTech Limited
(ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500; F: +61 8 6141 3599 W: www.holistaco.com
ASX Announcement
4 March 2020
CONTROLLED PLACEMENT AGREEMENT
KUALA LUMPUR/PERTH, 4 March 2020 – Holista CollTech (ASX:HCT, “Holista”), as announced on the 11 February 2020, increased its Controlled Placement Agreement ( CPA ) limit with Acuity Capital to a maximum of $5,000,000.
The Company is pleased to announce that it has utilised the CPA to raise $1,700,000 (inclusive of costs) by agreeing to issue 10,625,000 HCT shares at an issue price of $0.16.
The issue price of $0.16 represents a discount of 10.2% to the 15 day VWAP up to 3 March 2020 (inclusive) and a 5.9% discount to the closing price of $0.17 on 3 March 2020.
The Company advises that total capital now provided utilising the CPA, including the $1.7m the subject of this announcement, is $4.33m.
The Company is therefore pleased to announce that Acuity Capital and Holista have agreed to increase the maximum amount of capital available under the CPA by an additional $5m (i.e. up to a maximum of $10m), taking the total amount now available under the CPA to $5.67m.
An Appendix 2A and cleansing document will follow on confirmation of share allotment today.
Authorised by: Stuart Usher Company Secretary
#END OF PRESS RELEASE#
About Holista CollTech Ltd
Holista CollTech Ltd (“Holista”) is a research-driven biotech company, the result of a merger between Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth and with extensive operations in Malaysia, the company is dedicated to delivering first-class natural ingredients and wellness products globally. Holista is a leader in the research of herbs and ingredients for the making of healthier food.
Listed on the Australian Securities Exchange (“ASX”), Holista researches, develops, manufactures and markets “health-style” products to address the unmet and evolving needs of natural medicine. Holista’s suite of ingredients, among other things, includes low-GI baked products, reduced-sodium
salts, low-fat fried foods and low calories sugar without compromising taste, odour and mouthfeel. Holista remains the only company to produce sheep (ovine) collagen using patented extraction methods.
For more information, please refer to http://www.holistaco.com
For further information, please contact:
Corporate Affairs & Business Opportunities
Dr Rajen Manicka: [email protected] General Enquiries: [email protected]
Australia
283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599
Malaysia
12th Floor, Amcorp Trade Centre, PJ Tower No. 18, Persiaran Barat off Jalan Timur 46000, Petaling Jaya, Malaysia P: +603 7965 2828 ; F: +603 7965 2777
Media and Investor Relations Enquiries
WeR1 Consultants Pte Ltd 3 Phillip Street #12-01 Singapore 048693 E: [email protected]; P: +65 67374844